BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$90.02 USD
0.00 (0.00%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $90.00 -0.02 (-0.02%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/6/24 |
---|---|
Current Quarter | 0.77 |
EPS Last Quarter | 0.96 |
Last EPS Surprise | 68.42% |
ABR | 1.48 |
Earnings ESP
|
0.68% |
---|---|
Current Year | 3.18 |
Next Year | 3.97 |
EPS (TTM) | 2.62 |
P/E (F1) | 28.27 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 706.49M | 734.08M | 2.81B | 3.10B |
# of Estimates | 10 | 10 | 9 | 10 |
High Estimate | 727.08M | 753.30M | 2.82B | 3.29B |
Low Estimate | 679.42M | 720.20M | 2.79B | 2.89B |
Year ago Sales | 581.33M | 646.21M | 2.42B | 2.81B |
Year over Year Growth Est. | 21.53% | 13.60% | 16.02% | 10.49% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.77 | 0.79 | 3.18 | 3.97 |
# of Estimates | 12 | 10 | 13 | 12 |
Most Recent Consensus | 0.71 | 0.83 | 3.20 | 4.12 |
High Estimate | 0.84 | 0.86 | 3.30 | 4.93 |
Low Estimate | 0.71 | 0.72 | 2.79 | 3.03 |
Year ago EPS | 0.46 | 0.49 | 2.08 | 3.18 |
Year over Year Growth Est. | 67.39% | 61.22% | 52.88% | 24.59% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 1 |
Up Last 30 Days | 6 | 2 | 12 | 10 |
Up Last 60 Days | 6 | 2 | 12 | 9 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 6 | 0 | 1 |
Down Last 60 Days | 1 | 6 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.77 | 0.79 | 3.18 | 3.97 |
7 Days Ago | 0.77 | 0.79 | 3.18 | 3.95 |
30 Days Ago | 0.74 | 0.83 | 2.78 | 3.65 |
60 Days Ago | 0.74 | 0.83 | 2.78 | 3.66 |
90 Days Ago | 0.67 | 0.75 | 2.61 | 3.40 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.77 | 0.79 | 3.22 | 4.03 |
Zacks Consensus Estimate | 0.77 | 0.79 | 3.18 | 3.97 |
Earnings ESP | 0.68% | -0.22% | 1.03% | 1.60% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.96 | 0.71 | 0.49 | 0.46 | NA |
Estimate | 0.57 | 0.60 | 0.44 | 0.46 | NA |
Difference | 0.39 | 0.11 | 0.05 | 0.00 | 0.14 |
Surprise | 68.42% | 18.33% | 11.36% | 0.00% | 24.53% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more